Arix Bioscience plc: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics

Arix co-leads EUR 20 million Series A investment round in new portfolio company STipe Arix further strengthens position in oncology; investment in STipe increases oncology portfolio to six companies Dr Christian Schetter, Entrepreneur in Residence at... Biopharmaceuticals, Venture Capital Arix Bioscience, STipe Therapeutics, STING Pathway
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news